Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 461699-81-0 | MDL No. : | MFCD06795657 |
Formula : | C13H20BNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KEMUFKXFCINKAA-UHFFFAOYSA-N |
M.W : | 249.11 | Pubchem ID : | 17750207 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With tetrakis(triphenylphosphine) palladium(0); cesium fluoride; In methanol; 1,2-dimethoxyethane; at 150℃; for 0.166667h;Microwave irradiation; | Preparation 53 (1154) -(1 ,2-dimethyl-1 /-/-imidazol-5-yl)-2-methoxyaniline (1155) (1156) A suspension of 2-methoxy-4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)aniline (925 mg, 3.71 mmol), 5-bromo-1 ,2-dimethylimidazole (650 mg, 3.71 mmol), CsF (1 .7 g, 1 1 .14 mmol) and Pd(PPh3)4 (86 mg, 0.074 mmol) in DME/MeOH (2:1 , 18 mL) was heated to 1 50C for 10 minutes under microwave irradiation. The reaction mixture was diluted with EtOAc and water. The aqueous layer was basified by addition of 2M aqueous Na2C03 and extracted with EtOAc. The combined organic layers were washed with brine, dried (MgS04) and concentrated in vacuo. The residue was purified by reverse phase column chromatography eluting with 1 00% water to afford the title compound (800 mg, 99%). (1157) 1 H NMR (500 MHz, MeOH-d4) delta ppm 6.84 (d, J = 2.0 Hz, 1 H), 6.81 (s, 1 H), 6.78 (d, J = 2.0 Hz, 1 H), 6.75 (s, 1 H), 3.88 (s, 3H), 3.53 (s, 3H), 2.41 (s, 3H). (1158) HRMS (ESI) MS m/z calcd for C12H16N3O [M+H]+ 218.1288 , found 21 8.1200. |
42% | With cesium fluoride;tetrakis(triphenylphosphine) palladium(0); In methanol; 1,2-dimethoxyethane; at 150℃; for 1h;Microwave irradiation; | Preparation 95: 4-(1 ,2-Dimethyl-1 H-imidazol-5-yl)-2-methoxyaniline; [00265] To a microwave vial was added 5-bromo-1 ,2-dimethyl-1 /-/-imidazole (230mg, 1 .31 mmol), 2-methoxy-4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)aniline (393mg, 1 .58mmol), Pd(PPh3)4 (152mg, 0.13mmol), CsF (599mg, 3.94mmol) and DME/MeOH 3/1 (4ml_). The mixture was heated in a microwave at 150C for 1 hour. The reaction mixture was then filtered and concentrated onto silica gel and purified by Biotage silica gel column chromatography eluting with (EtOAc/MeOH 100/0 to 96/4) to give the title product as a light brown oil (120mg, 42 %). 1 H NMR (500 MHz, CDCI3): delta 2.43 (s, 3H), 3.48 (s, 3H), 3.87 (s, 3H), 6.73-6.78 (m, 3H), 6.87 (s, 1 H). LC (Method A)-MS (ESI, m/z) tR 0.49 min, 218 [(M+H+), 100%]. |
42% | With tetrakis(triphenylphosphine) palladium(0); cesium fluoride; In methanol; 1,2-dimethoxyethane; at 150℃; for 1h;Microwave irradiation; | Preparation 95 4-(1,2-Dimethyl-1H-imidazol-5-yl)-2-methoxyaniline To a microwave vial was added <strong>[24134-09-6]5-bromo-1,2-dimethyl-1H-imidazole</strong> (230 mg, 1.31 mmol), 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (393 mg, 1.58 mmol), Pd(PPh3)4 (152 mg, 0.13 mmol), CsF (599 mg, 3.94 mmol) and DME/MeOH 3/1 (4 mL). The mixture was heated in a microwave at 150 C. for 1 hour. The reaction mixture was then filtered and concentrated onto silica gel and purified by Biotage silica gel column chromatography eluting with (EtOAc/MeOH 100/0 to 96/4) to give the title product as a light brown oil (120 mg, 42%). 1H NMR (500 MHz, CDCl3): delta 2.43 (s, 3H), 3.48 (s, 3H), 3.87 (s, 3H), 6.73-6.78 (m, 3H), 6.87 (s, 1H). LC (Method A)-MS (ESI, m/z) tR 0.49 min, 218 [(M+H+), 100%]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; water; at 150℃; for 1h;Microwave irradiation; | Prepared using method C (Preparation 85) in DME/water 3/1 for 1 hour at 150 C. under microwave irradiation. Purified using silica gel column chromatography eluting with 5% (7M ammonia in methanol) in ethyl acetate to afford the title compound as a purple powder (40 mg, 46%). 1H NMR (500 MHz, CDCl3) delta 2.38 (s, 3H), 3.84 (s, br, 2H), 3.87 (s, 3H), 3.88 (s, 3H), 6.74 (d, J=7.9 Hz, 1H), 6.83 (m, 2H), 7.71 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In tetrahydrofuran; water; at 100.0℃; for 18h;Microwave irradiation; | General procedure: Preparation 45 (1126) -methoxy-4-(1 -methyl-1 -/-pyrazol-3-yl)aniline (1127) (1128) To a solution of 2-methoxy-4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)aniline (310 mg, 1 .244 mmol) and 3-bromo-1 -methyl-1 -/-pyrazole (154 mg, 0.957 mmol) in THF (3 ml_) was added Pd(dppf)Cl2-DCM (40 mg, 0.049 mmol) and 2M aqueous Na2CC>3 (1 ml_) and the reaction was heated to 65 C for 18 hours. The reaction was diluted with EtOAc and water. The aqueous layer was extracted with EtOAc, the combined organic layers were washed with water and brine, dried (MgS04) and concentrated in vacuo. The residue was purified by silica gel column chromatography eluting with 0-60% EtOAc in cyclohexane to afford the title compound (34 mg, 18%). (1129) 1 H NMR (500 MHz, CDCI3): delta ppm 7.33 (d, J = 18.8 Hz, 2H), 7.28 (d, J = 1 .2 Hz, 2H), 7.20 (d, J = 7.9 Hz, 1 H), 6.74 (dd, J = 7.9, 1 .2 Hz, 1 H), 6.45 (dd, J = 2.2, 1 .2 Hz, 1 H), 3.95 (m, 6H), 3.85 (br s, 2H). (1130) HRMS (ESI) MS m/z calcd for C11 H14N3O [M+H]+ 204.1 131 , found 204.1 141 . |
[ 1000339-10-5 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 325142-84-5 ]
2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.84
[ 365564-07-4 ]
2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 171364-79-7 ]
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 864772-18-9 ]
4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane
Similarity: 0.82
[ 1000339-10-5 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 325142-84-5 ]
2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.84
[ 365564-07-4 ]
2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 171364-79-7 ]
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 864772-18-9 ]
4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane
Similarity: 0.82
[ 1000339-10-5 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 325142-84-5 ]
2-(3-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.84
[ 365564-07-4 ]
2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 171364-79-7 ]
2-(4-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.83
[ 864772-18-9 ]
4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane
Similarity: 0.82
[ 1000339-10-5 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 214360-73-3 ]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.79
[ 627899-90-5 ]
N,N-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-1-amine
Similarity: 0.79
[ 210907-84-9 ]
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.78
[ 191171-55-8 ]
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.75